Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Arc Tx ARCT Stock Why Institutions Own It 011 20260418 Is Salesforce CRM stock breaking out Trend Strengthens 20260418 What Gloo Holdings GLOO auditor changes mean for investors Gloo Holdings Posts Wider Loss Amid Cost Pressure ARK Innovation ETF ARKK Should investors enter SiteOne SITE stock today SiteOne notches 328 EPS beat despite quarterly loss Coda Octopus CODA beats Q1 earnings by 26 yet shares decline despite EPS outperformance Why is AXT AXTI stock volatile today AXT narrows loss beats EPS consensus by 145 SpaceX Shareholders Approve 5for1 Stock Split Ahead of Highly Anticipated Nasdaq Debut Fed Rate Hike Expectations Surge as Inflation Data Shifts Market Sentiment Alico ALCO Q1 2026 Earnings Surprise EPS 149 Up Significant Waystar Holding WAY Flat at 1867 Consolidation Continues 20260514 Underweight Position in Vertiv Holdings Weighs on Fidelity Growth Strategies Funds Q1 Results OFG Bancorp OFG Q1 2026 Earnings EPS 126 Beats Estimates LG Energy Solution Shares Jump 16 on Major US Battery Storage Contract ThirdParty Payments for Mutual Funds Get Regulatory Nod But Salary Deductions Not Allowed ExCIA Chief Petraeus Suggests Iran Could Open Strait of Hormuz in Peace Deal Perpetua Resources Secures 29 Billion US Loan for Idaho Gold and Antimony Project Berkshire Hathaway Rebuilds Airline Position with 26 Billion Delta Air Lines Stake Australia Files A2B Lawsuit Against 3M Over PFAS Contamination at Defence Sites RMBS Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Despite Shortfall ASTC Q1 2024 Earnings Loss Per Share Reported Amid No Revenue Stock Declines CBRE Q1 2026 Earnings Strong EPS Beat Despite Revenue Uncertainty Stock Slips WAVE Q1 2026 Earnings Strong EPS Beat Amid No Revenue Stock Declines GPK Q1 2026 Earnings EPS Surges 56 Above Estimates Stock Jumps 515 OLLI Q1 2026 Earnings EPS Misses Estimates Despite Solid Performance Shares Dip Greenwich LifeSciences GLSI Surges 7 as Biotech Momentum Builds Rentokil Initial RTO Slips 07 as Traders Weigh Support and Resistance Levels CytomX Therapeutics CTMX Holds Steady Near Resistance After 325 Gain 4D Molecular Therapeutics FDMT Surges 310 Biotech Momentum Builds Ames National Corporation ATLO Holds Steady Near 287 Amid Subdued Trading